Montelukast Sodium Market
Montelukast Sodium Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Montelukast Sodium Market Size and Growth
The Montelukast Sodium market is experiencing notable growth, driven by increasing asthma and allergy prevalence. Current market size is estimated at approximately $1.5 billion, with projections indicating continued expansion due to rising awareness, enhanced healthcare access, and a growing geriatric population. Competitive dynamics highlight both generic and branded therapies.
Companies Covered
(Covid 19 Impact Covered)
◍ Morepen Laboratories
◍ Mylan
◍ TAPI
◍ MSN Laboratories
◍ Ultratech India
◍ Aurobindo Pharma
◍ Hetero Labs
◍ Unimark Remedies
◍ Jubilant Cadista
◍ Aamorb Pharmaceuticals
◍ Sudarshan Group
◍ Ortin Laboratories
◍ Vamsi Labs
◍ Adley Group
◍ Medopharm
◍ Hengyuan Pharmaceutical
◍ Arromax Pharmaceutical Technology
The Montelukast Sodium market features companies like Morepen Laboratories, Mylan, and Aurobindo Pharma manufacturing and distributing the drug. These firms enhance market growth through innovation, strategic partnerships, and competitive pricing. Notable sales revenue figures include:
- Mylan: ~$11 billion
- Aurobindo Pharma: ~$1.5 billion
- Jubilant Cadista: ~$300 million.
◍ Lihe Wuhan New Chemical
Request Sample Report
Materials
Market Segmentation
By Application
Tablets
Chewable Tablet
Oral Solution
Request Sample Report
By Product
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Market Growth
Request Sample Report
$ X Billion USD
